182 results
Page 4 of 10
8-K
EX-99.2
yy5bqqom uqj
19 Nov 20
Aravive Announces Phase 3 Trial Design for AVB-500 in Platinum Resistant Ovarian Cancer
7:10am
8-K
EX-10.1
giae5jmdojxzdw
10 Nov 20
Entry into a Material Definitive Agreement
7:10am
8-K
EX-99.1
o63gehfcjqr
8 Oct 20
Regulation FD Disclosure
5:01pm
8-K
7puox4 gz8v7dcj
14 Sep 20
Submission of Matters to a Vote of Security Holders
4:59pm
8-K
EX-99.2
imrmnx641t00zjp m3o
23 Jul 20
Aravive Announces Successful Completion of Phase 1b Trial Evaluating AVB-500
7:05am
8-K
e85y2
23 Jul 20
Aravive Announces Successful Completion of Phase 1b Trial Evaluating AVB-500
7:05am
8-K
EX-99.1
b8c7c2r1lcy90xnstnjs
23 Jul 20
Aravive Announces Successful Completion of Phase 1b Trial Evaluating AVB-500
7:05am
424B3
ea4uat6e1z33h1
14 Jul 20
Prospectus supplement
4:05pm